[EP4] 教育企画4(第1部 特別講演 6)
PADに対するIVRを始めよう

[SL6（EP4-2）] Current status of paclitaxel-coated devices for the treatment of peripheral arterial disease

^○Michael Dake (University of Arizona Health Sciences)

〈略　暦〉
Senior Vice President, UA Health Sciences
Professor, Department of Medical Imaging
Professor, Department of Surgery
Professor, Department of Medicine

Michael D. Dake, MD, directs strategic integration of undergraduate and graduate education, research, service and clinical activities in the UA Health Sciences colleges, centers and clinical affiliates. Dr. Dake is a leading researcher, clinician, teacher, and administrator. He is internationally known for pioneering image-guided therapies and novel approaches in interventional therapy in the fields of vascular imaging, venous thromboembolic disease, aortic aneurysms, and dissection. Dr. Dake made medical history with the implantation of the world’s first thoracic stent-graft in 1992 and his groundbreaking research with CT angiography and stent-grafts has re-written medical and surgery textbooks. Prior to joining the UA, he served at Stanford University as Professor of Cardiothoracic Surgery and Director of the Catheterization and Angiography Laboratories at Stanford Medical Center, where he spent much of his career. Previously, he served as Chairman of the Department of Radiology in the Virginia Health System. He is a graduate of Harvard College and Baylor College of Medicine, where he completed an internship, residency and chief residency in internal medicine. He pursued fellowship training in pulmonary diseases followed by a residency and chief residency in radiology at the University of California San Francisco. He went on to complete subspecialty training in vascular and interventional radiology at UCSF. As a member of the UA’s senior executive team, Dr. Dake works collaboratively with teams throughout the UA and with Banner Health to build the UA’s competitiveness in education, clinical care and biomedical research.